AJOG: Comparative Effectiveness of Treating Prenatal Depression with Counseling versus Antidepressants in Relation to Preterm Delivery

Comparative Effectiveness of Treating Prenatal Depression with Counseling versus Antidepressants in Relation to Preterm Delivery – ScienceDirect Abstract Background Maternal depression during pregnancy is prevalent and has been associated with…

Read More from AJOG: Comparative Effectiveness of Treating Prenatal Depression with Counseling versus Antidepressants in Relation to Preterm Delivery

AJOG: Insights from Preventability Assessments Across 42 State and City Maternal Mortality Reviews in the United States

Insights from Preventability Assessments Across 42 State and City Maternal Mortality Reviews in the United States – ScienceDirect Abstract Background The rising trend in maternal mortality over the past three…

Read More from AJOG: Insights from Preventability Assessments Across 42 State and City Maternal Mortality Reviews in the United States

AJOG: Aspirin for evidence-based preeclampsia prevention trial: effects of aspirin on maternal serum pregnancy-associated plasma protein A and placental growth factor trajectories in pregnancy

Aspirin for evidence-based preeclampsia prevention trial: effects of aspirin on maternal serum pregnancy-associated plasma protein A and placental growth factor trajectories in pregnancy – American Journal of Obstetrics & Gynecology…

Read More from AJOG: Aspirin for evidence-based preeclampsia prevention trial: effects of aspirin on maternal serum pregnancy-associated plasma protein A and placental growth factor trajectories in pregnancy

AJOG: Congenital Syphilis in Live Births – Adverse Outcomes, Hospital Length of Stay, and Costs

Obstetrics & Gynecology (lww.com) OBJECTIVE:  To examine temporal trends and risk factors for congenital syphilis in newborn hospitalizations and to evaluate the association between adverse outcomes and congenital syphilis and…

Read More from AJOG: Congenital Syphilis in Live Births – Adverse Outcomes, Hospital Length of Stay, and Costs

AJOG: Immediate Postpartum Long-Acting Reversible Contraception for Preventing Severe Maternal Morbidity – A Cost-Effective Analysis

Obstetrics & Gynecology (lww.com) OBJECTIVE:  To estimate the cost effectiveness of Medicaid covering immediate postpartum long-acting reversible contraception (LARC) as a strategy to reduce future short interpregnancy interval (IPI), severe…

Read More from AJOG: Immediate Postpartum Long-Acting Reversible Contraception for Preventing Severe Maternal Morbidity – A Cost-Effective Analysis

AJOG: Optimizing Opioid Prescription Quantity After Cesarean Delivery – A Randomized Controlled Trial

Obstetrics & Gynecology (lww.com) OBJECTIVE:  To test whether an individualized opioid-prescription protocol (IOPP) with a shared decision-making component can be used without compromising postcesarean pain management. METHODS:  In this multicenter…

Read More from AJOG: Optimizing Opioid Prescription Quantity After Cesarean Delivery – A Randomized Controlled Trial

AJOG: Aspirin 162 mg versus 81 mg for Preeclampsia Prophylaxis in High-risk Obese Individuals: A Comparative Effectiveness Open Label Randomized Trial (ASPREO)

Aspirin 162 mg versus 81 mg for Preeclampsia Prophylaxis in High-risk Obese Individuals: A Comparative Effectiveness Open Label Randomized Trial (ASPREO) – American Journal of Obstetrics & Gynecology (ajog.org) ABSTRACT:…

Read More from AJOG: Aspirin 162 mg versus 81 mg for Preeclampsia Prophylaxis in High-risk Obese Individuals: A Comparative Effectiveness Open Label Randomized Trial (ASPREO)

AJOG: Mean Arterial Pressure and Neonatal Outcomes in Pregnancies Complicated by Mild Chronic Hypertension

Obstetrics & Gynecology (lww.com) OBJECTIVE:  To estimate the association between mean arterial pressure during pregnancy and neonatal outcomes in participants with chronic hypertension using data from the CHAP (Chronic Hypertension…

Read More from AJOG: Mean Arterial Pressure and Neonatal Outcomes in Pregnancies Complicated by Mild Chronic Hypertension

AJOG: Neonatal outcomes associated with in utero cannabis exposure: a population-based retrospective cohort study

Background The full spectrum of associations between in utero cannabis exposure and adverse neonatal outcomes is still unclear. Objective This study aimed to evaluate the associations between in utero cannabis…

Read More from AJOG: Neonatal outcomes associated with in utero cannabis exposure: a population-based retrospective cohort study

AJOG: Effectiveness of care bundles for prevention and treatment of postpartum hemorrhage: a systematic review

Objective Care bundles are a promising approach to reducing postpartum hemorrhage–related morbidity and mortality. We assessed the effectiveness and safety of care bundles for postpartum hemorrhage prevention and/or treatment. Effectiveness…

Read More from AJOG: Effectiveness of care bundles for prevention and treatment of postpartum hemorrhage: a systematic review

AJOG: Pregnancy-Related Deaths Due to Hemorrhage: Pregnancy Mortality Surveillance System, 2012–2019

ABSTRACT: Hemorrhage has been a leading cause of pregnancy-related death in the Centers for Disease Control and Prevention Pregnancy Mortality Surveillance System since 1987 when reporting began. Pregnancy Mortality Surveillance…

Read More from AJOG: Pregnancy-Related Deaths Due to Hemorrhage: Pregnancy Mortality Surveillance System, 2012–2019

AJOG: Postpartum pharmacologic thromboprophylaxis and complications in a US cohort

Postpartum pharmacologic thromboprophylaxis and complications in a US cohort Background Venous thromboembolism accounts for approximately 9% of pregnancy-related deaths in the United States. National guidelines recommend postpartum risk stratification and pharmacologic prophylaxis in…

Read More from AJOG: Postpartum pharmacologic thromboprophylaxis and complications in a US cohort

AJOG: Society for Maternal-Fetal Medicine Special Statement: Prophylactic low-dose aspirin for preeclampsia prevention—quality metric and opportunities for quality improvement

Society for Maternal-Fetal Medicine Special Statement: Prophylactic low-dose aspirin for preeclampsia prevention—quality metric and opportunities for quality improvement Prophylactic low-dose aspirin reduces the rates of preeclampsia, preterm birth, fetal growth…

Read More from AJOG: Society for Maternal-Fetal Medicine Special Statement: Prophylactic low-dose aspirin for preeclampsia prevention—quality metric and opportunities for quality improvement

AJOG: Cost-effectiveness of induction of labor at 39 weeks vs expectant management by cervical examination

Cost-effectiveness of induction of labor at 39 weeks vs expectant management by cervical examination Background Previous analyses have demonstrated the cost effectiveness of elective induction of labor at 39 weeks…

Read More from AJOG: Cost-effectiveness of induction of labor at 39 weeks vs expectant management by cervical examination

AJOG: Examining recent trends in spontaneous and iatrogenic preterm birth across race and ethnicity in a large managed care population

Examining recent trends in spontaneous and iatrogenic preterm birth across race and ethnicity in a large managed care population Background For the past several decades, epidemiological studies originating from the…

Read More from AJOG: Examining recent trends in spontaneous and iatrogenic preterm birth across race and ethnicity in a large managed care population

AJOG: Optimizing the management of acute, prolonged decelerations and fetal bradycardia based on the understanding of fetal pathophysiology

Optimizing the management of acute, prolonged decelerations and fetal bradycardia based on the understanding of fetal pathophysiology Any acute and profound reduction in fetal oxygenation increases the risk of anaerobic…

Read More from AJOG: Optimizing the management of acute, prolonged decelerations and fetal bradycardia based on the understanding of fetal pathophysiology